Novel Biomarkers of Habitual Alcohol Intake and Associations with Risk of Pancreatic and Liver Cancers and Liver Disease Mortality
(2021) In Journal of the National Cancer Institute 113(11). p.1542-1550- Abstract
BACKGROUND: Alcohol is an established risk factor for several cancers, but modest alcohol-cancer associations may be missed due to measurement error in self-reported assessments. Biomarkers of habitual alcohol intake may provide novel insight into the relationship between alcohol and cancer risk.
METHODS: Untargeted metabolomics was used to identify metabolites correlated with self-reported habitual alcohol intake in a discovery dataset from the European Prospective Investigation into Cancer and Nutrition (EPIC; n = 454). Statistically significant correlations were tested in independent datasets of controls from case-control studies nested within EPIC (n = 280) and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC; n =... (More)
BACKGROUND: Alcohol is an established risk factor for several cancers, but modest alcohol-cancer associations may be missed due to measurement error in self-reported assessments. Biomarkers of habitual alcohol intake may provide novel insight into the relationship between alcohol and cancer risk.
METHODS: Untargeted metabolomics was used to identify metabolites correlated with self-reported habitual alcohol intake in a discovery dataset from the European Prospective Investigation into Cancer and Nutrition (EPIC; n = 454). Statistically significant correlations were tested in independent datasets of controls from case-control studies nested within EPIC (n = 280) and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC; n = 438) study. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of alcohol-associated metabolites and self-reported alcohol intake with risk of pancreatic cancer, hepatocellular carcinoma (HCC), liver cancer, and liver disease mortality in the contributing studies.
RESULTS: Two metabolites displayed a dose-response association with self-reported alcohol intake 2-hydroxy-3-methylbutyric acid and an unidentified compound. A 1-SD (log2) increase in levels of 2-hydroxy-3-methylbutyric acid was associated with risk of HCC (OR = 2.54; 95% CI = 1.51-4.27) and pancreatic cancer (OR = 1.43; 95% CI = 1.03-1.99) in EPIC and liver cancer (OR = 2.00; 95% CI = 1.44-2.77) and liver disease mortality (OR = 2.16; 95% CI = 1.63-2.86) in ATBC. Conversely, a 1-SD (log2) increase in questionnaire-derived alcohol intake was not associated with HCC or pancreatic cancer in EPIC or liver cancer in ATBC but was associated with liver disease mortality (OR = 2.19; 95% CI = 1.60-2.98) in ATBC.
CONCLUSIONS: 2-Hydroxy-3-methylbutyric acid is a candidate biomarker of habitual alcohol intake that may advance the study of alcohol and cancer risk in population-based studies.
(Less)
- author
- organization
- publishing date
- 2021-05-19
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of the National Cancer Institute
- volume
- 113
- issue
- 11
- pages
- 1542 - 1550
- publisher
- Oxford University Press
- external identifiers
-
- pmid:34010397
- scopus:85121055459
- ISSN
- 1460-2105
- DOI
- 10.1093/jnci/djab078
- language
- English
- LU publication?
- yes
- id
- 6fc62c8e-9ca6-4c56-9823-6bf2de6b467f
- date added to LUP
- 2021-08-11 14:55:53
- date last changed
- 2023-11-23 05:41:58
@article{6fc62c8e-9ca6-4c56-9823-6bf2de6b467f, abstract = {{<p>BACKGROUND: Alcohol is an established risk factor for several cancers, but modest alcohol-cancer associations may be missed due to measurement error in self-reported assessments. Biomarkers of habitual alcohol intake may provide novel insight into the relationship between alcohol and cancer risk.</p><p>METHODS: Untargeted metabolomics was used to identify metabolites correlated with self-reported habitual alcohol intake in a discovery dataset from the European Prospective Investigation into Cancer and Nutrition (EPIC; n = 454). Statistically significant correlations were tested in independent datasets of controls from case-control studies nested within EPIC (n = 280) and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC; n = 438) study. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of alcohol-associated metabolites and self-reported alcohol intake with risk of pancreatic cancer, hepatocellular carcinoma (HCC), liver cancer, and liver disease mortality in the contributing studies.</p><p>RESULTS: Two metabolites displayed a dose-response association with self-reported alcohol intake 2-hydroxy-3-methylbutyric acid and an unidentified compound. A 1-SD (log2) increase in levels of 2-hydroxy-3-methylbutyric acid was associated with risk of HCC (OR = 2.54; 95% CI = 1.51-4.27) and pancreatic cancer (OR = 1.43; 95% CI = 1.03-1.99) in EPIC and liver cancer (OR = 2.00; 95% CI = 1.44-2.77) and liver disease mortality (OR = 2.16; 95% CI = 1.63-2.86) in ATBC. Conversely, a 1-SD (log2) increase in questionnaire-derived alcohol intake was not associated with HCC or pancreatic cancer in EPIC or liver cancer in ATBC but was associated with liver disease mortality (OR = 2.19; 95% CI = 1.60-2.98) in ATBC.</p><p>CONCLUSIONS: 2-Hydroxy-3-methylbutyric acid is a candidate biomarker of habitual alcohol intake that may advance the study of alcohol and cancer risk in population-based studies.</p>}}, author = {{Loftfield, Erikka and Stepien, Magdalena and Viallon, Vivian and Trijsburg, Laura and Rothwell, Joseph A and Robinot, Nivonirina and Biessy, Carine and Bergdahl, Ingvar A and Bodén, Stina and Schulze, Matthias B and Bergman, Manuela and Weiderpass, Elisabete and Schmidt, Julie A and Zamora-Ros, Raul and Nøst, Therese H and Sandanger, Torkjel M and Sonestedt, Emily and Ohlsson, Bodil and Katzke, Verena and Kaaks, Rudolf and Ricceri, Fulvio and Tjønneland, Anne and Dahm, Christina C and Sánchez, Maria-Jose and Trichopoulou, Antonia and Tumino, Rosario and Chirlaque, María-Dolores and Masala, Giovanna and Ardanaz, Eva and Vermeulen, Roel and Brennan, Paul and Albanes, Demetrius and Weinstein, Stephanie J and Scalbert, Augustin and Freedman, Neal D and Gunter, Marc J and Jenab, Mazda and Sinha, Rashmi and Keski-Rahkonen, Pekka and Ferrari, Pietro}}, issn = {{1460-2105}}, language = {{eng}}, month = {{05}}, number = {{11}}, pages = {{1542--1550}}, publisher = {{Oxford University Press}}, series = {{Journal of the National Cancer Institute}}, title = {{Novel Biomarkers of Habitual Alcohol Intake and Associations with Risk of Pancreatic and Liver Cancers and Liver Disease Mortality}}, url = {{http://dx.doi.org/10.1093/jnci/djab078}}, doi = {{10.1093/jnci/djab078}}, volume = {{113}}, year = {{2021}}, }